'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” ...

Jim Cramer, host of Mad Money, recently shared his thoughts following his interview with President-elect Donald Trump on the floor of the New York Stock Exchange. One of the key takeaways for ...

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts ... as he mentioned Morgan Stanley's Benjamin ...

We recently published a list of 10 Jim Cramer Stocks to Watch in 2025. In this article, we are going to take a look at where ...

Pfizer (PFL) announced it is spinning off its off-patent drug business and combining it with Real Money Stock of the ... Here's what Cramer had to say. "So let's watch Merck, cause Merck has ...

Jim Cramer is steering investors toward quantum computing stocks while expressing concerns about Super Micro Computer Inc.

CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique ...

CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...

Cramer agreed with Goldman Sachs' Eric Sheridan, who suggested that Uber can produce mid-to-high teens growth in mobility ...